» Articles » PMID: 35126120

Platelet Mechanobiology Inspired Microdevices: From Hematological Function Tests to Disease and Drug Screening

Overview
Journal Front Pharmacol
Date 2022 Feb 7
PMID 35126120
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet function tests are essential to profile platelet dysfunction and dysregulation in hemostasis and thrombosis. Clinically they provide critical guidance to the patient management and therapeutic evaluation. Recently, the biomechanical effects induced by hemodynamic and contractile forces on platelet functions attracted increasing attention. Unfortunately, the existing platelet function tests on the market do not sufficiently incorporate the topical platelet mechanobiology at play. Besides, they are often expensive and bulky systems that require large sample volumes and long processing time. To this end, numerous novel microfluidic technologies emerge to mimic vascular anatomies, incorporate hemodynamic parameters and recapitulate platelet mechanobiology. These miniaturized and cost-efficient microfluidic devices shed light on high-throughput, rapid and scalable platelet function testing, hematological disorder profiling and antiplatelet drug screening. Moreover, the existing antiplatelet drugs often have suboptimal efficacy while incurring several adverse bleeding side effects on certain individuals. Encouraged by a few microfluidic systems that are successfully commercialized and applied to clinical practices, the microfluidics that incorporate platelet mechanobiology hold great potential as handy, efficient, and inexpensive point-of-care tools for patient monitoring and therapeutic evaluation. Hereby, we first summarize the conventional and commercially available platelet function tests. Then we highlight the recent advances of platelet mechanobiology inspired microfluidic technologies. Last but not least, we discuss their future potential of microfluidics as point-of-care tools for platelet function test and antiplatelet drug screening.

Citing Articles

NebulaPlate: a droplet microfluidic platform to analyze platelet aggregation.

Jiang Z, Wei M, Zhu J, Wang C, Zhang T, Zhu W J Nanobiotechnology. 2025; 23(1):171.

PMID: 40045357 PMC: 11881362. DOI: 10.1186/s12951-025-03212-5.


Design of 3D printed chip to improve sensitivity of platelet adhesion through reinjection: Effect of alcohol consumption on platelet adhesion.

Kim H, Park H, Song J, Yeom E Biomicrofluidics. 2025; 19(1):014101.

PMID: 39759388 PMC: 11699976. DOI: 10.1063/5.0237452.


Multi-parametric thrombus profiling microfluidics detects intensified biomechanical thrombogenesis associated with hypertension and aging.

Din M, Paul S, Ullah S, Yang H, Xu R, Abidin N Nat Commun. 2024; 15(1):9067.

PMID: 39433750 PMC: 11494109. DOI: 10.1038/s41467-024-53069-9.


Harnessing the power of bioprinting for the development of next-generation models of thrombosis.

Liu Y, Huang T, Yap N, Lim K, Ju L Bioact Mater. 2024; 42:328-344.

PMID: 39295733 PMC: 11408160. DOI: 10.1016/j.bioactmat.2024.08.040.


Multi-parametric thrombus profiling microfluidics detects intensified biomechanical thrombogenesis associated with hypertension and aging.

Din M, Paul S, Ullah S, Yang H, Xu R, Abidin N bioRxiv. 2024; .

PMID: 38915705 PMC: 11195082. DOI: 10.1101/2024.06.11.598290.


References
1.
Jenny L, Melmer A, Laimer M, Hardy E, Lam W, Schroeder V . Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study. Diab Vasc Dis Res. 2020; 17(1):1479164120903044. PMC: 7510361. DOI: 10.1177/1479164120903044. View

2.
Ju L, McFadyen J, Al-Daher S, Alwis I, Chen Y, Tonnesen L . Compression force sensing regulates integrin αβ adhesive function on diabetic platelets. Nat Commun. 2018; 9(1):1087. PMC: 5852038. DOI: 10.1038/s41467-018-03430-6. View

3.
Furie K, Cushman M, Elkind M, Lyden P, Saposnik G . Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke. 2021; 52(7):2478-2482. DOI: 10.1161/STROKEAHA.121.035564. View

4.
McFadyen J, Schaff M, Peter K . Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol. 2018; 15(3):181-191. DOI: 10.1038/nrcardio.2017.206. View

5.
Liu L, Zhang Q, Xiao S, Sun Z, Ding S, Chen Y . Inhibition of Shear-Induced Platelet Aggregation by Xueshuantong via Targeting Piezo1 Channel-Mediated Ca Signaling Pathway. Front Pharmacol. 2021; 12:606245. PMC: 8025832. DOI: 10.3389/fphar.2021.606245. View